Broadwood Partners, L.P.
10% owner at STAAR Surgical; Director at Lineage Cell Therapeutics; 10% owner at Insight Molecular Diagnostics.
- Rank
- 192nd of 809
- Companies held
- 3
- Largest holding
- STAA, 89.6% of total
- Latest SEC filing
- Nov 17, 2026
- Listed but not counted
- $380M
What the $861M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| STAAR Surgical STAA Common Stock | Directly | 15,426,144 | $25.03 | $386M | 44.8% | Form 4, Jan 8, 2026 |
| STAAR Surgical STAA Common Stock | Indirectly (see filing footnote) | 15,426,144 | $25.03 | $386M | 44.8% | Form 4, Jan 8, 2026 |
| Lineage Cell Therapeutics LCTX Common Shares | Directly | 50,560,992 | $0.82 | $41.5M | 4.8% | Form 4, Nov 17, 2026 |
| Insight Molecular Diagnostics IMDX Common Stock, no par value | Directly | 16,113,455 | $1.66 | $26.7M | 3.1% | Form 4, Nov 17, 2026 |
| Insight Molecular Diagnostics IMDX Common Stock, no par value | Indirectly (see filing footnote) | 12,684,884 | $1.66 | $21.1M | 2.4% | Form 4, Apr 27, 2026 |
Share counts are the amounts Broadwood Partners, L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Broadwood Partners, L.P.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| STAAR Surgical STAA Common Stock | Through Broadwood Partners, L.P. Held by a company or fund the insider manages | 12,455,264 | $25.03 | $312M | — | Form 4, Mar 31, 2025 |
| Lineage Cell Therapeutics LCTX Common Shares | Through Broadwood Partners, L.P. Held by a company or fund the insider manages | 50,560,992 | $0.82 | $41.5M | — | Form 4, Nov 17, 2026 |
| Insight Molecular Diagnostics IMDX Common Stock, no par value | Through Broadwood Partners, L.P. Held by a company or fund the insider manages | 16,113,455 | $1.66 | $26.7M | — | Form 4, Nov 17, 2026 |
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Bought | IMDX | 3,428,571 | $1.75 | $6.0M | View |
| Nov 17, 2026 | Bought | LCTX | 1,000,000 | $0.77 | $771K | View |
| Apr 27, 2026 | Bought | IMDX | 250,923 | $3.64 | $913K | View |
| Apr 24, 2026 | Bought | IMDX | 38,880 | $3.53 | $137K | View |
| Apr 23, 2026 | Bought | IMDX | 280,381 | $3.50 | $981K | View |
| Jan 8, 2026 | Bought | STAA | 3,240 | $21.94 | $71K | View |
| Jan 7, 2026 | Bought | STAA | 66,467 | $22.00 | $1.5M | View |
| Jan 6, 2026 | Bought | STAA | 150,000 | $22.38 | $3.4M | View |
| Jan 6, 2026 | Bought | STAA | 186,946 | $21.01 | $3.9M | View |
| Nov 21, 2025 | Bought | STAA | 797,486 | $27.86 | $22.2M | View |
| Nov 20, 2025 | Bought | STAA | 393,382 | $27.14 | $10.7M | View |
| Nov 19, 2025 | Bought | STAA | 309,132 | $26.42 | $8.2M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 189 | Tco Group Holdings, L.P. 10% owner, InnovAge Holding | $901M |
| 190 | CD&R Fund X Waterworks B1, L.P. 10% owner, Core & Main | $882M |
| 191 | Leonard Green & Partners, L.P. 10% owner, WESCO International | $873M |
| 192 | Broadwood Partners, L.P. 10% owner, STAAR Surgical | $861M |
| 193 | American International Group, Inc. 10% owner, Corebridge Financial | $855M |
| 194 | STEINER LEISURE Ltd Director, OneSpaWorld Holdings | $838M |
| 195 | Glencore plc 10% owner, Century Aluminum | $837M |
Other STAAR Surgical insiders
All STAA insiders- Aimee S. Weisner$384KDirector. #7321 overall
- Gilbert H. Kliman$262KDirector. #4742 overall
Questions
How much stock does Broadwood Partners, L.P. own?
Broadwood Partners, L.P. holds $861,498,025 in listed stock based on SEC filings and current prices, mostly STAAR Surgical (STAA). That ranks 192nd on the Stock Rich List.
Is this Broadwood Partners, L.P.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Broadwood Partners, L.P. last buy or sell stock?
The most recent open-market trade on file is a purchase of 3,428,571 IMDX shares on Nov 17, 2026 at $1.75.
Files jointly with SEC filer 1278388.